Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Stroke

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Stroke in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's5 (71.43)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiao, Y; Sun, MY; Tian, X; Wang, DQ; Wang, ZG1
Satoh, K1
Chinybaeva, LA1
Anlar, O; Atbas, C; Tombul, T1
Buchanan, MR1
Adunsky, A; Hershkowitz, M1
Aguilar, J; Giménez, R1

Reviews

2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Stroke

ArticleYear
[Stroke, platelet activating factor and receptor antagonists].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2017, Volume: 42, Issue:24

    Topics: Cerebrovascular Disorders; Humans; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, G-Protein-Coupled; Stroke

2017
[Plasma platelet-activating factor acetylhydrolase (PAF-AH) deficiency as a risk factor for stroke].
    Brain and nerve = Shinkei kenkyu no shinpo, 2008, Volume: 60, Issue:11

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Humans; Mutation, Missense; Platelet Activating Factor; Risk Factors; Stroke

2008

Other Studies

5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Stroke

ArticleYear
[Comparative characterization of hemostatic parameters in patients with cerebral stroke].
    Klinicheskaia meditsina, 2004, Volume: 82, Issue:7

    Topics: Brain; Female; Hemostasis; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation Inhibitors; Severity of Illness Index; Stroke

2004
Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2005, Volume: 12, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; beta-Thromboglobulin; Biomarkers; Cerebral Infarction; Disability Evaluation; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Hemostatics; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Factor 4; Predictive Value of Tests; Risk Factors; Stroke

2005
Biological basis and clinical implications of acetylsalicylic acid resistance.
    The Canadian journal of cardiology, 2006, Volume: 22, Issue:2

    Topics: Acetylation; Acetyltransferases; Arachidonic Acid; Aspirin; Drug Resistance; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Stroke; Thromboxane A2

2006
Binding of platelet-activating factor to platelets of ischemic stroke patients.
    The journals of gerontology. Series A, Biological sciences and medical sciences, 1998, Volume: 53, Issue:4

    Topics: Aged; Analysis of Variance; Blood Platelets; Brain Ischemia; Chi-Square Distribution; Female; Humans; Male; Platelet Activating Factor; Prospective Studies; Statistics, Nonparametric; Stroke

1998
Cytidine (5') diphosphocholine-induced decrease in cerebral platelet activating factor is due to inactivation of its synthesizing enzyme cholinephosphotransferase in aged rats.
    Neuroscience letters, 2001, Feb-23, Volume: 299, Issue:3

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aging; Animals; Cell Membrane; Cerebral Cortex; Cytidine Diphosphate Choline; Diacylglycerol Cholinephosphotransferase; Food, Formulated; Isoenzymes; Male; Nootropic Agents; Phospholipases A; Platelet Activating Factor; Rats; Rats, Wistar; Stroke; Subcellular Fractions

2001